Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Share Price
NASDAQ: KNSAHealthcare
Live Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Share Price Chart
O H L
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Performance Overview
Days Range
▼
$78.16Low
$79.25High
Markets Today
| Previous Close | $79.33 |
|---|---|
| Open | $78.30 |
| Volume | 51,722 |
| Day's Range | $78.16 - $79.25 |
| 52W Range | $35.20 - $82.94 |
| Market Cap | $6.06 B |
Historical Performance
| 1M Returns | -0.20 |
|---|---|
| 3M Returns | +43.95 |
| 6M Returns | +75.70 |
| 1Y Returns | +120.85 |
| 5Y Returns | +550.78 |
| 10Y Returns | NA |
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Fundamentals
| Market Cap | $6.06 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 78.97 |
| PEG Ratio | N/A |
| Revenue | $677.56 M |
| ROE TTM | 0.12 |
| EPS TTM | $0.98 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 9.26 |
| EBITDA | $78.78 M |
| Profit Margin | 8.71 |
| Market Cap | $6.06 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 78.97 |
| PEG Ratio | N/A |
| Revenue | $677.56 M |
| ROE TTM | 0.12 |
| EPS TTM | $0.98 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 9.26 |
| EBITDA | $78.78 M |
| Profit Margin | 8.71 |
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $137.78 M | $156.80 M | $180.85 M | $202.13 M | $214.27 M | $243.60 M |
| Gross Profit + | $119.92 M | $138.19 M | $160.60 M | $181.18 M | $193.47 M | $220.03 M |
| Operating Income | $13.27 M | $20.16 M | $24.02 M | $19.77 M | $29.27 M | $27.19 M |
| EBITDA | $13.62 M | $20.52 M | $24.43 M | $20.23 M | $29.73 M | $27.67 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $345.00 K | $358.00 K | $408.00 K | $467.00 K | $468.00 K | $472.00 K |
| Income Before Tax | $15.56 M | $22.88 M | $27.16 M | $23.27 M | $32.68 M | $31.14 M |
| Income Tax Expense | $7.03 M | $5.04 M | $8.72 M | $9.07 M | $10.09 M | $5.71 M |
| Net Income + | $8.54 M | $17.83 M | $18.43 M | $14.20 M | $22.59 M | $25.43 M |
| Net Profit Margin | 6.2% | 11.37% | 10.19% | 7.02% | 10.54% | 10.44% |
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $20.00 K | $21.00 K | $21.00 K | $21.00 K | $21.00 K | $21.00 K |
| Reserve & Surplus | -$512.77 M | -$494.82 M | -$476.49 M | -$462.16 M | -$440.21 M | -$415.49 M |
| Non-Current Liabilities | $44.57 M | $48.32 M | $53.36 M | $56.84 M | $62.98 M | $70.71 M |
| Current Liabilities | $97.27 M | $117.83 M | $123.59 M | $139.18 M | $156.61 M | $171.25 M |
| Total Liabilities | $141.84 M | $166.14 M | $176.95 M | $196.03 M | $219.59 M | $241.96 M |
| Fixed Assets | $16.61 M | $16.83 M | $17.16 M | $17.19 M | $16.99 M | $17.32 M |
| Current Assets | $355.91 M | $420.31 M | $475.53 M | $527.18 M | $594.17 M | $668.63 M |
| Total Assets | $599.33 M | $661.15 M | $712.33 M | $763.63 M | $825.28 M | $896.11 M |
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $8.54 M | $17.83 M | $18.43 M | $14.20 M | $22.59 M | $25.43 M |
| Operating Cash Flow | $22.32 M | $28.09 M | $33.68 M | $53.89 M | $50.20 M | $47.20 M |
| Investing Cash Flow | -$51.54 M | -$3.88 M | -$62.76 M | -$70.81 M | -$31.92 M | -$73.58 M |
| Financing Cash Flow | $2.77 M | $10.70 M | $11.90 M | $7.66 M | $6.07 M | $12.11 M |
| Change in Cash | -$26.45 M | $34.91 M | -$17.18 M | -$9.26 M | $24.36 M | -$14.28 M |
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Return Calculator
The Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$64,118
Invested Amount$10,000
Est. Returns$54,118
About Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Popular Stocks
FAQs
What is the share price of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares today?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) share price as of September 18, 2026 is $78.16. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares?
Yes, Indian Investors can invest in the Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) Share by opening an international trading account with Angel One.
How can I purchase Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares shares in India?
Purchasing Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares?
Yes, you can purchase fractional shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares on September 18, 2026, is $6.06 B.
In which sector Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares belongs?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares stocks?
In order to invest in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
